TRUP
Trupanion (TRUP)
NASDAQ
$29.35+$0.03 (+0.11%)
Price as of Oct 23, 2026 7:55 PM EDT
  • $1.3B
    Market Cap
  • -33.06%
    1-Year Change
  • Insurance - Property & Casualty
    Industry

Key Performance

More
  • Earnings Score: 57
  • Momentum Score: 20
  • True Yield: N/A
  • Financial Health Score: 71
TradeSmith Loading

Latest Research & News

Lacy Pushes Trupanion Past $4 Billion in Paid Claims, Helping More than 3.9 Million Pets Receive Care

Trupanion, North America's leading pet medical insurer, has surpassed $4 billion in paid claims, reaching this milestone in just 18 months after hitting $3 billion. The company now supports over 3.9 million pets and processes an average of $59.8 million in claims monthly across 190,000+ claims. Trupanion's VetDirect Pay technology has enabled over 2.6 million claims to be paid in under 60 seconds, helping pet families access care without financial barriers.

05/26/2026, 11:00 AM • GlobeNewswire

Trupanion Launches 2026 Veterinary Appreciation Day® Awards with New Team Excellence Category

Trupanion, a leading pet medical insurance provider in North America, has opened nominations for its annual Veterinary Appreciation Day Awards. The company introduced a new award category this year—Veterinary Team of the Year—to recognize the collaborative efforts of entire clinic teams. The nomination period runs from April 16 to May 7, 2026, with voting from May 12-26 and winners announced on June 18, 2026.

04/16/2026, 11:00 AM • GlobeNewswire

Trupanion's CFO Just Sold His Last Share. The Filing Explains Why

Trupanion CFO Fawwad Qureshi sold his final 2,837 shares on February 27, 2026, completing a systematic divestment plan initiated in May 2025. The sale, executed under a pre-planned 10b5-1 trading plan for financial diversification, was not discretionary and should not be viewed as a negative signal about the company's prospects. This was the seventh and final transaction in a series of identical-sized sales scheduled in advance.

03/24/2026, 7:10 PM • The Motley Fool

PRISM MarketView Launches PetCare Index

PRISM MarketView launched the PRISM PetCare Index to track publicly traded companies driving growth in the global pet care sector, projected to exceed $350 billion. The index includes companies advancing veterinary services, pet pharmaceuticals, insurance, diagnostics, and premium nutrition. Key companies highlighted include Elanco Animal Health, Chewy, and Trupanion, which are positioned to benefit from increasing consumer spending on pet healthcare, preventative services, and subscription-based offerings.

02/12/2026, 10:00 AM • GlobeNewswire

Read This Before Buying Chewy Stock​

Chewy is a successful e-commerce pet retailer with over 130,000 products, but the article advises caution before investing. While the company showed 8.3% year-over-year revenue growth in Q3 2025 with improving profit margins, structural challenges persist. With net profit margins around 2% and the entire pet industry characterized by low margins, Chewy's growth prospects appear limited. The author recommends staying on the sidelines until profitability improves and valuation drops.

01/25/2026, 12:05 PM • The Motley Fool

Peers

Statistics

More
Day Range
$28.81
$30.00
$29.32
1-Year Range
$21.46
$43.80
$29.32
Latest Close$29.32
Change
-$0.59 (-2.01%)
Volume288,369
Market Cap$1.3B
Shares Outstanding43.9M
P/E (TTM)56.56
Diluted EPS (TTM)$0.53
Enterprise Value$1.3B

Information as of 10/23/2026

Company Profile

$1.3B
Market Cap
$23.2M
Net Income
Sector: Financial Services
Industry: Insurance - Property & Casualty
6100 4th Avenue South, Seattle, WA, United States, 98108
855 727 9079

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. and changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

Key Executives

  • Margaret Rosemary Maria Tooth
  • Fawwad Qureshi
  • Brenna McGibney
  • John Gallagher
  • Steve Weinrauch BVMS MRCVS

Current Ownership Distribution

  • Institutions769.6M (77.97%)
  • Mutual Funds213.6M (21.64%)
  • Insiders3.9M (0.39%)
  • Other0 (0.00%)